In patients with severe COVID-19, the activity of NK cells in peripheral blood and bronchoalveolar lavage (BAL) increased, although the IFN response was blunted because the NK population was redistributed to BAL as a result of increased chemokines in BAL in patients with severe COVID-1940,41. This evidence concerns the gene IFNA1 and COVID-19.